FDA Approves Leqembi: What You Should Know

CareTalk Podcast

FDA Approves Leqembi: What You Should Know

July 11, 2023

FDA Approves Leqembi: What You Should Know

FDA just approved Leqembi, a drug to slow the cognitive decline of Alzheimer’s patients, and Medicare has agreed to pay for it. Is it time for patients, families and physicians to be excited? Or do we need to temper our hopes?

CareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy.

Become a CareTalk sponsor
Guest appearance requests
Visit us on the web

Apple Podcasts
Google Podcasts
Follow us on LinkedIn

#leqembi #alzheimers #pharma #FDA #medicare #medicaid #aduhelm

Subscribe to the CareTalk Newsletter to access exclusive content and insights covering the biggest topics in healthcare today.

Check out the CareTalk Store for official merch!

CareTalk is produced by Grippi Media

Listen on your favorite player

New to Podcasts? It's easy to get started!

You may also like

Top Health Podcasts. Delivered to Your Inbox and Eardrums.

Join Our Newsletter

We gratefully acknowledge the many organizations that have generously supported our podcasts and platform.

Network Sponsors and Advertisers

Event and Media Partners

Buffer LinkedIn WhatsApp